HSIC vs. PDCO, BIO, BIO.B, CHE, PEN, QGEN, SWAV, THC, CTLT, and ASND
Should you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Patterson Companies (PDCO), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Chemed (CHE), Penumbra (PEN), Qiagen (QGEN), Shockwave Medical (SWAV), Tenet Healthcare (THC), Catalent (CTLT), and Ascendis Pharma A/S (ASND). These companies are all part of the "medical" sector.
Patterson Companies (NASDAQ:PDCO) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, community ranking, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.
In the previous week, Patterson Companies had 7 more articles in the media than Henry Schein. MarketBeat recorded 16 mentions for Patterson Companies and 9 mentions for Henry Schein. Patterson Companies' average media sentiment score of 0.88 beat Henry Schein's score of 0.18 indicating that Henry Schein is being referred to more favorably in the news media.
Henry Schein has a net margin of 3.37% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 20.98% beat Patterson Companies' return on equity.
Patterson Companies has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500.
Henry Schein received 7 more outperform votes than Patterson Companies when rated by MarketBeat users. However, 52.49% of users gave Patterson Companies an outperform vote while only 51.55% of users gave Henry Schein an outperform vote.
Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.
79.2% of Patterson Companies shares are held by institutional investors. Comparatively, 93.3% of Henry Schein shares are held by institutional investors. 1.5% of Patterson Companies shares are held by company insiders. Comparatively, 1.1% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Patterson Companies currently has a consensus price target of $33.11, indicating a potential upside of 22.36%. Henry Schein has a consensus price target of $81.09, indicating a potential upside of 9.66%. Given Henry Schein's higher probable upside, analysts clearly believe Patterson Companies is more favorable than Henry Schein.
Summary
Henry Schein beats Patterson Companies on 11 of the 18 factors compared between the two stocks.
Get Henry Schein News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Henry Schein Competitors List
Related Companies and Tools